Request for TOC Request for Sample
BUY NOW

U.S. Spinal Implants Market – Industry Trends and Forecast to 2028

Healthcare | Published Report | Jun 2021 | Country Level | 350 Pages | No of Tables: 46 | No of Figures: 38
Nucleus

Circumvent the Tariff challenges with an agile supply chain Consulting

Supply Chain Ecosystem Analysis now part of DBMR Reports

Us Spinal Implants Market

Market Size in USD Billion

CAGR :  %

USD 2,663.90 Million USD 4,046.30 Million 2020 2028
Forecast Period
2021 –2028
Market Size(Base Year)
USD 2,663.90 Million
Market Size (Forecast Year)
USD 4,046.30 Million
CAGR
%
Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

U.S. Spinal Implants Market, By Product (Fusion Devices, Non-Fusion Devices, Spine Biologics, Spine Bone Stimulators and Others), Material (Metals, Ceramic, Biomaterial, Polymers and Others), Technology (Fusion, Spine Biologics, VCF, Decompression, Motion Preservation and Others), Surgery Type (Open Surgeries and Minimally Invasive Surgeries), End User (Hospitals, Specialty Clinics, Spine Centers, Trauma Centers, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender and Retail Sales), Industry Trends and Forecast to 2028

Market Analysis and Insights: U.S. Spinal Implants Market

U.S. spinal implants market is expected to reach USD 4,046.30 million by 2028, from USD 2,663.90 million in 2020, growing at the CAGR of 5.1% in the forecast period of 2021 to 2028. U.S. spinal implants market is expected to grow due to the progress in the demand for spinal implants in healthcare facilities, due to the rising incidence of scoliosis, kyphosis, degenerative spinal disorder, degenerative disc diseases and geriatric population in the U.S.

Spinal implants are devices that surgeons utilize during surgery to manage disorders related to the spine and mitigate back pain and strengthen the spine. These implants are made of bio-compatible and body-friendly materials widely used in treating spinal injuries such as Degenerative Disc Diseases, Degenerative Spinal Disorders, scoliosis, kyphosis, and others. Minimally invasive surgeries are done using spinal implants for the treatment of spinal injuries and lumbar spinal stenosis. The increased risk of spinal disorders are seen in the geriatric population due to their poor tolerance of immobilization, poor nutritional status and bone quality. This affirmative factor acts as a driver for the growth of the spinal implants market in the region. Spinal implants can be of four types, fusion devices, non-fusion devices, spine biologics, and spine bone stimulators. They are made up of various materials like metals, ceramic, polymers, and biomaterials.

Spinal implants are used to substitute or support missing or damaged parts of the spinal cord or nerves at a spinal canal in the patient's body. The spinal implants are envisioned to treat the malformations or fractures to stabilize body posture and reinstate normal spinal function. The spinal implants market has beheld a shift due to advancements in technology, leading to change from conventional surgical procedures to modern fixation, fusion, and prosthetic devices. The demand for spinal implants has increased considerably due to the rise in the geriatric population, which further increases the risk of various spinal disorders like spinal stenosis and kyphosis, among others. However, stringent government policies for spinal implants' approval and the high cost associated with procedures involving spinal implants and spinal bone stimulators treatment can hamper the spinal implants market growth.

The spinal implants market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Get Exclusive Sample Copy of this Report Here
U.S. Spinal Implants Market Scope and Market Size

U.S. spinal implants market is categorized into six notable segments based on product, materials, technology, surgery type, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the spinal implants market is segmented into fusion devices, non-fusion devices, spine biologics, spine bone stimulators and others. In 2021, the fusion devices segment is expected to dominate the market due to escalation in the geriatric populace leading to increased incidence of degenerative spinal disorders, degenerative disc diseases, and other spinal disorders.
  • On the basis of material, the spinal implants market is segmented into metals, ceramic, biomaterial, polymers and others. In 2021, the metals segment is expected to dominate the market due to the cost-effectiveness and wide applications of these materials.
  • On the basis of technology, the spinal implants market is segmented into fusion, spine biologics, VCF, decompression, motion preservation and others. In 2021, the fusion segment is expected to dominate the market due to the rise in incidences of target diseases such as degenerative disc disease and spinal stenosis and due to lesser complications.
  • On the basis of surgery type, the spinal implants market is segmented into open surgeries and minimally invasive surgeries. In 2021, the open surgeries segment is expected to dominate the market due to the rising incidence of spinal deformities, surging preference for open spine surgeries among medical professionals, and the technological advancements in spinal fusion surgeries.
  • On the basis of end user, the spinal implants market is segmented into hospitals, specialty clinics, spine centers, trauma centers, ambulatory surgical centers (ASCS), and others. In 2021, the hospital segment is expected to dominate the market by end user because hospitals are the primary procurement of services in an accident or injury requiring any spine surgeons.
  • On the basis of distribution channel, the implants market is segmented into direct tender and retail sales. In 2021, the direct tender segment is expected to dominate the market as it provides quality and accessible spinal implant products to various hospitals, spine and trauma centers.

New Product Launches by Manufactures is Creating New Opportunities for Players in the Spinal Implants market

Spinal implants market also provides you with detailed market analysis for every country growth in aesthetic industry with spinal implants market sales, impact of advancement in the spinal implants market and changes in regulatory scenarios with their support for the spinal implants market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Spinal implants market Share Analysis

Spinal implants market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to spinal implants market.

Some of the major players operating in the U.S. spinal implants market are Medtronic, Canwell Medical Co., Ltd., NuVasive, Inc., SeaSpine, Globus Medical, RTI Surgical, MW Industries, Inc. (MWI), Captiva Spine, Inc., XTANT MEDICAL, SINTX Technologies, Inc, Orthofix Medical, Inc., Alphatec Holdings, Inc., Wenzel Spine, Inc., Johnson & Johnson Services, Inc., Tecomet, Inc., Stryker, and Zimmer Biomet, Axial Medical, NORMAN NOBLE, INC., and Spine Wave among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the spinal implants market.

For instance,

  • In February 2021, Medtronic announced that major surgeons have utilized Medtronic’s newly approved Midas Rex and Mazor Robotic guidance system for successfully performing minimally invasive spinal procedures. This has become the next step in spine surgeries, thereby increased credibility and revenue over the market.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the spinal implants market which also provides the benefit for organisation to improve their offering for spinal implants market.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF U.S. SPINAL IMPLANTS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET END USER COVERAGE GRID

2.8 PRODUCTS TYPE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 PREMIUM INSIGHTS

4 MARKET OVERVIEW

4.1 DRIVERS

4.1.1 RISING GERIATRIC POPULATION

4.1.2 INCREASING RISK OF SPINAL DEFORMITIES AND DISORDERS

4.1.3 TECHNOLOGICAL ADVANCEMENT IN SPINAL IMPLANTS

4.1.4 GROWTH IN AWARENESS ABOUT SPINAL IMPLANTS

4.2 RESTRAINTS

4.2.1 HIGH COST ASSOCIATED WITH PROCEDURES INVOLVING SPINAL IMPLANTS TREATMENT

4.2.2 PRODUCT RECALL

4.3 OPPORTUNITIES

4.3.1 RISING HEALTHCARE INFRASTRUCTURE

4.3.2 INCREASE IN DEMAND FOR MINIMALLY INVASIVE SURGERIES

4.3.3 INCREASING NUMBER OF SPINAL INJURIES AND SPORT ACCIDENTS

4.3.4 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS

4.4 CHALLENGES

4.4.1 INADEQUATE REIMBURSEMENT COVERAGE

4.4.2 STRINGENT GOVERNMENT POLICIES FOR APPROVAL OF SPINAL IMPLANTS

4.4.3 SIDE-EFFECTS OF SPINAL IMPLANTS

4.4.4 PANDEMIC OUTBREAK OF COVID-19

5 IMPACT OF COVID-19 ON THE U.S. SPINAL IMPLANTS MARKET

5.1 IMPACT ON PRICE

5.2 IMPACT ON DEMAND

5.3 IMPACT ON SUPPLY

5.4 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS

5.5 CONCLUSION

6 U.S. SPINAL IMPLANTS MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 FUSION DEVICES

6.2.1 THORACIC FUSION DEVICES

6.2.1.1 ANTERIOR THORACIC FUSION DEVICES

6.2.1.1.1 CAGES

6.2.1.1.2 ROD

6.2.1.1.3 PLATES

6.2.1.2 POSTERIOR THORACIC FUSION DEVICES

6.2.1.2.1 CAGES

6.2.1.2.2 ROD

6.2.1.2.3 PLATES

6.2.2 LUMBAR INTERBODY FUSION DEVICES

6.2.2.1 ANTERIOR LUMBAR INTERBODY FUSION DEVICES

6.2.2.2 POSTERIOR LUMBAR INTERBODY FUSION DEVICES

6.2.2.3 TRANSFORAMINAL LUMBAR INTERBODY FUSION DEVICES

6.2.2.4 AXIAL LUMBAR INTERBODY FUSION DEVICES

6.2.3 CERVICAL FUSION DEVICES

6.2.3.1 ANTERIOR CERVICAL FUSION

6.2.3.2 ANTERIOR CERVICAL PLATES

6.2.3.3 CERVICAL INTERBODY FUSION DEVICES

6.2.3.4 ANTERIOR CERVICAL SCREW SYSTEMS

6.2.4 POSTERIOR CERVICAL FUSION

6.2.4.1 POSTERIOR CERVICAL PLATES

6.2.4.2 POSTERIOR CERVICAL SCREWS

6.2.4.3 POSTERIOR CERVICAL RODS

6.3 NON FUSION DEVICES

6.3.1 DYNAMIC STABILIZATION DEVICES

6.3.1.1 INTERSPINOUS PROCESS SPACERS

6.3.1.2 PEDICLE-BASED DYNAMIC ROD DEVICES

6.3.1.3 FACET REPLACEMENT PRODUCTS

6.3.2 ARTIFICAL DISCS

6.3.2.1 ARTIFICIAL CERVICAL DISCS

6.3.2.2 ARTIFICIAL LUMBAR DISCS

6.3.3 ANNULUS REPAIR DEVICES

6.3.4 NUCLEAR DISC PROSTHESES

6.3.5 OTHERS

6.4 SPINE BILIOGICS

6.4.1 DEMINERALIZED BONE MATRIX

6.4.2 BONE MORPHOGENETIC PROTEINS

6.4.3 BONE SUBSTITUTES

6.4.4 MACHINED BONES

6.4.5 CELL-BASED MATRICES

6.4.6 ALLOGRAFTS

6.5 SPINE BONE STIMULATORS

6.5.1 NON-INVASIVE SPINE BONE STIMULATORS

6.5.2 INVASIVE SPINE BONE STIMULATORS

6.6 OTHERS

7 U.S. SPINAL IMPLANTS MARKET, BY MATERIAL

7.1 OVERVIEW

7.2 METALS

7.2.1 TITANIUM AND ALLOYS

7.2.2 POLYETHERETHERKETONE (PEEK)

7.2.2.1 HYDROXYAPATITE PEEK

7.2.2.2 TITANIUM PEEK

7.2.3 STAINLESS STEEL

7.2.4 SILICON NITRIDE

7.2.5 TANTALUM

7.2.6 OTHERS

7.3 CERAMIC

7.4 BIOMATERIAL

7.5 POLYMER

7.6 OTHERS

8 U.S. SPINAL IMPLANTS MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 FUSION

8.3 VCF

8.4 SPINE BIOLOGICS

8.5 DECOMPRESSION

8.6 MOTION PRESERVATION

8.7 OTHERS

9 U.S. SPINAL IMPLANTS MARKET, BY SURGERY TYPE

9.1 OVERVIEW

9.2 OPEN SURGERIES

9.2.1 FUSION DEVICES

9.2.2 NON FUSION DEVICES

9.2.3 SPINE BIOLOGICS

9.2.4 SPINE BONE STIMULATORS

9.2.5 OTHERS

9.3 MINIMALLY INVASIVE SURGERIES

9.3.1 FUSION DEVICES

9.3.2 NON FUSION DEVICES

9.3.3 SPINE BIOLOGICS

9.3.4 SPINE BONE STIMULATORS

9.3.5 OTHERS

10 U.S. SPINAL IMPLANTS MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 SPECIALTY CLINICS

10.4 SPINE CENTERS

10.5 TRAUMA CENTERS

10.6 AMBULATORY SURGICAL CENTERS (ASCS)

10.7 OTHERS

11 U.S. SPINAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDERS

11.3 RETAIL SALES

12 U.S.

13 THE U.S. SPINAL IMPLANTS MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: THE U.S.

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 STRYKER

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 PRODUCT PORTFOLIO

15.1.4 RECENT DEVELOPMENTS

15.2 MEDICAL DEVICES BUSINESS SERVICES, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 PRODUCT PORTFOLIO

15.2.4 RECENT DEVELOPMENTS

15.3 MEDTRONIC

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENTS

15.4 NUVASIVE, INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 ZIMMER BIOMET

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENTS

15.6 ORTHOFIX MEDICAL INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 GLOBUS MEDICAL

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENTS

15.8 ATEC SPINE, INC

15.8.1 COMPANY SNAPSHOT

15.8.2 REVENUE ANALYSIS

15.8.3 PRODUCT PORTFOLIO

15.8.4 RECENT DEVELOPMENTS

15.9 AXIAL MEDICAL

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 CANWELL MEDICAL CO., LTD.

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 CAPTIVA SPINE, INC.

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 MW INDUSTRIES, INC. (MWI)

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENTS

15.13 NORMAN NOBLE, INC

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 RTI SURGICAL

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUE ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENTS

15.15 SEASPINE

15.15.1 COMPANY SNAPSHOT

15.15.2 REVENUE ANALYSIS

15.15.3 PRODUCT PORTFOLIO

15.15.4 RECENT DEVELOPMENTS

15.16 SINTX TECHNOLOGIES, INC.

15.16.1 COMPANY SNAPSHOT

15.16.2 REVENUE ANALYSIS

15.16.3 PRODUCT PORTFOLIO

15.16.4 RECENT DEVELOPMENTS

15.17 SPINE WAVE, INC.

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENTS

15.18 TECOMET, INC.

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENTS

15.19 WENZEL SPINE, INC.

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENTS

15.2 XTANT MEDICAL

15.20.1 COMPANY SNAPSHOT

15.20.2 REVENUE ANALYSIS

15.20.3 PRODUCT PORTFOLIO

15.20.4 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1 U.S. SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 2 U.S. FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 3 U.S. THORACIC FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 4 U.S. ANTERIOR THORACIC FUSION IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 5 U.S. POSTERIOR THORACIC FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 6 U.S. LUMBAR INTERBODY FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 7 U.S. CERVICAL FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 8 U.S. ANTERIOR CERVICAL FUSION IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 9 U.S. POSTERIOR CERVICAL FUSION IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 10 U.S. NON-FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 11 U.S. DYNAMIC STABILIZATION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 12 U.S. ARTIFICIAL DISCS IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 13 U.S. SPINE BIOLOGICS IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 14 U.S. SPINE BONE STIMULATOR IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 15 U.S. SPINAL IMPLANTS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 16 U.S. METALS IN SPINAL IMPLANTS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 17 U.S. POLYETHERETHERKETONE (PEEK) IN SPINAL IMPLANTS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 18 U.S. SPINAL IMPLANTS MARKET, BY TECHNOLOGY, 2019-2028, (USD MILLION)

TABLE 19 U.S. SPINAL IMPLANTS MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 20 U.S. OPEN SURGERIES IN SPINAL IMPLANTS MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 21 U.S. MINIMALLY INVASIVE SURGERIES IN SPINAL IMPLANTS MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 22 U.S. SPINAL IMPLANTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 23 U.S. SPINAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 24 U.S. SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 25 U.S. FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 26 U.S. THORACIC FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 27 U.S. ANTERIOR THORACIC FUSION IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 28 U.S. POSTERIOR FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 29 U.S. LUMBAR INTERBODY FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 30 U.S. CERVICAL FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 31 U.S. ANTERIOR CERVICAL FUSION IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 32 U.S. POSTERIOR CERVICAL FUSION IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 33 U.S. NON-FUSION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 34 U.S. DYNAMIC STABILIZATION DEVICES IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 35 U.S. ARTIFICIAL DISCS IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 36 U.S. SPINE BIOLOGICS IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 37 U.S. SPINE BONE STIMULATORS IN SPINAL IMPLANTS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 38 U.S. SPINAL IMPLANTS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 39 U.S. METALS IN SPINAL IMPLANTS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 40 U.S. POLYETHERETHERKETONE (PEEK) IN SPINAL IMPLANTS MARKET, BY MATERIAL, 2019-2028 (USD MILLION)

TABLE 41 U.S. SPINAL IMPLANTS MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 42 U.S. SPINAL IMPLANTS MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 43 U.S. OPEN SURGERIES IN SPINAL IMPLANTS MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 44 U.S. MINIMALLY INVASIVE SURGERIES IN SPINAL IMPLANTS MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 45 U.S. SPINAL IMPLANTS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 46 U.S. SPINAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

List of Figure

FIGURE 1 U.S. SPINAL IMPLANTS MARKET: SEGMENTATION

FIGURE 2 U.S. SPINAL IMPLANTS MARKET: DATA TRIANGULATION

FIGURE 3 U.S. SPINAL IMPLANTS MARKET: DROC ANALYSIS

FIGURE 4 U.S. SPINAL IMPLANTS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 U.S. SPINAL IMPLANTS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 U.S. SPINAL IMPLANTS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 U.S. SPINAL IMPLANTS MARKET: MARKET END USER COVERAGE GRID

FIGURE 8 U.S. SPINAL IMPLANTS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 U.S. SPINAL IMPLANTS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 U.S. SPINAL IMPLANTS MARKET: SEGMENTATION

FIGURE 11 INCREASED INCIDENCE OF SPINAL INJURIES AND GERIATRIC POPULACE IS EXPECTED TO DRIVE THE U.S. SPINAL IMPLANTS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 FUSION DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. SPINAL IMPLANTS MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE U.S. SPINAL IMPLANTS MARKET

FIGURE 14 U.S. SPINAL IMPLANTS MARKET: BY PRODUCT, 2020

FIGURE 15 U.S. SPINAL IMPLANTS MARKET: BY PRODUCT, 2019-2028 (USD MILLION)

FIGURE 16 U.S. SPINAL IMPLANTS MARKET: BY PRODUCT, CAGR (2021-2028)

FIGURE 17 U.S. SPINAL IMPLANTS MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 18 U.S. SPINAL IMPLANTS MARKET: BY MATERIAL, 2020

FIGURE 19 U.S. SPINAL IMPLANTS MARKET: BY MATERIAL, 2019-2028 (USD MILLION)

FIGURE 20 U.S. SPINAL IMPLANTS MARKET: BY MATERIAL, CAGR (2021-2028)

FIGURE 21 U.S. SPINAL IMPLANTS MARKET: BY MATERIAL, LIFELINE CURVE

FIGURE 22 U.S. SPINAL IMPLANTS MARKET: BY TECHNOLOGY, 2020

FIGURE 23 U.S. SPINAL IMPLANTS MARKET: BY TECHNOLOGY, 2019-2028 (USD MILLION)

FIGURE 24 U.S. SPINAL IMPLANTS MARKET: BY TECHNOLOGY, CAGR (2021-2028)

FIGURE 25 U.S. SPINAL IMPLANTS MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 26 U.S. SPINAL IMPLANTS MARKET: BY SURGERY TYPE, 2020

FIGURE 27 U.S. SPINAL IMPLANTS MARKET: BY SURGERY TYPE, 2019-2028 (USD MILLION)

FIGURE 28 U.S. SPINAL IMPLANTS MARKET: BY SURGERY TYPE, CAGR (2021-2028)

FIGURE 29 U.S. SPINAL IMPLANTS MARKET: BY SURGERY TYPE, LIFELINE CURVE

FIGURE 30 U.S. SPINAL IMPLANTS MARKET: BY END USER, 2020

FIGURE 31 U.S. SPINAL IMPLANTS MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 32 U.S. SPINAL IMPLANTS MARKET: BY END USER, CAGR (2021-2028)

FIGURE 33 U.S. SPINAL IMPLANTS MARKET: BY END USER, LIFELINE CURVE

FIGURE 34 U.S. SPINAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 35 U.S. SPINAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

FIGURE 36 U.S. SPINAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 37 U.S. SPINAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 38 THE U.S. SPINAL IMPLANTS MARKET: COMPANY SHARE 2020 (%)

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Testimonial
Claudio Rondena Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL
"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future